Medicinal Product Contraindication refers to the reason why a medicinal product is not to be used in a certain context. It cannot be ignored in the situations where the product must not be given for safety reasons e.g. concomitant disease, demographic factor or predisposition, concomitant use with another medicine etc. For example, hypersensitivity to the active substance or other excipient/residue should always be included in the summary of product characteristics of a medicinal product except for those exceptional circumstances where the expected benefit of the drug will be greater than the risk of hypersensitivity e.g. treatment of life-threatening condition with no alternative therapy.
Fast Healthcare Interoperability Resources (FHIR) is a draft standard describing data formats and elements (known as “resources”) and an application programming interface (API) for exchanging electronic health records. The standard was created by the Health Level Seven International (HL7) health-care standards organization.
Its goal is to facilitate interoperation between legacy healthcare systems, to make it easy to provide healthcare information to healthcare providers and individuals on a wide variety of devices from computers to tablets to cell phones, and to allow third-party application developers to provide medical applications which can be easily integrated into existing systems.
FHIR provides an alternative to document-centric approaches by directly exposing discrete data elements as services. For example, basic elements of healthcare like patients, admissions, diagnostic reports and medications can each be retrieved and manipulated via their own resource URLs (Uniform Resource Locators). FHIR was supported at an American Medical Informatics Association meeting by many EHR (Electronic health Record) vendors which value its open and extensible nature.